KVK taps Ram Kamineni for COO role

KVK-Tech and its affiliate Penn Life Sciences are welcoming Ram Kamineni as KVK-Tech's new COO.

Kamineni brings more than 38 years of pharma industry experience to the company. He most recently served as the senior vice president, head of global operations for Jubilant Pharma. Prior to that, he served as vice president, head of global OSD manufacturing strategy for Mylan. He also had several roles including Novartis, Patheon, and Merck Generics.

Kamineni will bring his diverse experience which includes: manufacturing and packaging of oral solids and liquids, sterile injectables  transdermal formulations, respiratory dosage forms, radio pharmaceuticals and API manufacturing.

“We are extremely pleased and excited to welcome Ram as our chief operating officer. With his unique experience and hands-on leadership philosophy, he is an excellent fit,” said KVK and PLS CEO, Anthony Tabasso. “We are confident Ram’s knowledge and expertise will further advance our goal to establish our company as a leader in the generics industry. I look forward to working closely with him as we build on our strong foundation to drive sustainable growth, with an emphasis on quality and compliance.”

Kamineni said, “With its exciting goals and compelling strategy, I believe KVK and PLS are well positioned for generational success.”